NCT02528773View on ClinicalTrials.gov

Efficacy of ART to Interrupt HIV Transmission Networks

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

September 9, 2014

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions
HIV
Trial Locations (1)

92103

UCSD AntiViral Research Center, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks | Biotech Hunter | Biotech Hunter